438
Participants
Start Date
March 31, 2008
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
FlutiForm 250/10
SKP FlutiForm 250/10ug is a HFA pMDI that delivers 125ug of Fluticasone propionate per actuation and 5ug of Formoterol fumarate per actuation. Patients will take 2 actuations BID for 12 weeks.
SKP-Fluticasone
SKP Fluticasone 250 ug is a HFA pMDI that delivers 125ug of Fluticasone propionate per actuation. Patients will take 2 actuations BID for 12 weeks.
Flovent Fluticasone HFA
Flovent 250 ug HFA is a pMDI that delivers after priming 125ug of Fluticasone propionate per actuation. Patients will take 2 actuations BID for 12 weeks.
Investigational Site, Lima
Investigational Site, Lima
Investigational Site, Lima
Investigational Site, Lima
Investigational Site, Lima
Investigational Site, Lima
Investigational Site, Caba
Investigational Site, Budapest
Investigational Site, Budapest
Investigational Site, Santa Fe
Investigational Site, Miskolc
Investigational Site, Miskolc
Investigational Site, San Miguel de Tucumán
Investigational Site, Durban
Investigational Site, Deszk
Investigational Site, Somerset West
Investigational Site, Tygerberg
Investigational Site, Cape Town
Investigational Site, Pécs
Investigational Site, Cape Town
Investigational Site, Bloemfontein
Investigational Site, Mexico City
Investigational Site, Vinnytsia
Investigational site, Richmond
Investigational site, Elizabeth City
Investigational Site, Chihuahua City
Investigational Site, Oldsmar
Investigational Site, Guerrero
Investigational site, Crestview Hills
Investigational Site, Jalisco
Investigational Site, Akron
Investigational Site, Jalisco
Investigational site, Cincinnati
Investigational Site, Indianapolis
Investigational Site, Dnipropetrovsk
Investigational Site, Dnipropetrovsk
Investigational Site, Dnipropetrovsk
Investigational Site, West Allis
Investigational Site, Michoacán
Investigational Site, Kharkiv
Investigational Site, Nuevo León
Investigational Site, Zaporizhzhya
Investigational Site, Zaporizhzhya
Investigational Site, Metarie
Investigational Site, Puebla City
Investigational Site, Austin
Investigational Site, Lviv
Investigational site, El Paso
Investigational Site, Luis Encinas S/N
Investigational Site, Donetsk
Investigational Site, Donetsk
Investigational site, Scottsdale
Investigational Site, Tempe
Investigational Site, Tabasco
Investigational site, Long Beach
Investigational Site, Encinitas
Investigational site, Orange
Investigational Site, Portland
Investigational Site, Craiova
Investigational Site, Brasov
Investigational Site, Palazu Mare
Investigational site, North Dartmouth
Investigational Site, Wellesley Hills
Investigational Site, East Providence
Investigational site, Providence
Investigational Site, Bahía Blanca
Investigational Site, Buenos Aires
Investigational Site, Buenos Aires
Investigational Site, Caba
Investigational Site, Buenos Aires
Investigational Site, Caba
Investigational Site, Caba
Investigational Site, Caba
Investigational Site, Caba
Investigational Site, Provincia de Buenos Aires
Investigational Site, Salta
Investigational Site, Santa Fe
Investigational Site, Concepción
Investigational Site, Rancagua
Investigational Site, Santiago
Investigational Site, San Bernardino
Investigational Site, Cusco
Investigational Site, Jesus Maria
Investigational Site, Lima Cercado
Investigational Site, Lodz
Investigational Site, Rzeszów
Investigational Site, Timișoara
Investigational Site, Mexico City
Investigational Site, Lima
Investigational Site, Gdansk
Investigational Site, Krakow
Investigational Site, Wroclaw
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Pretoria
Investigational Site, Pretoria
Investigational Site, Kiev
Investigational Site, Kiev
Investigational Site, Kiev
Collaborators (2)
Abbott
INDUSTRY
MDS Pharma Services
INDUSTRY
SkyePharma AG
INDUSTRY